Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 4394-4398, November 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imai, Y.
Right arrow Articles by Shiu, R. P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, Y.
Right arrow Articles by Shiu, R. P. C.

Epidermal Growth Factor Receptors and Effect of Epidermal Growth Factor on Growth of Human Breast Cancer Cells in Long-Term Tissue Culture1

Yasuo Imai2, Clement K. H. Leung, Henry G. Friesen and Robert P. C. Shiu

Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, R3E 0W3

Epidermal growth factor (EGF) may be important in regulating the proliferation of mammary epithelial cells. In the present study, we examined EGF binding and effect on growth in nine human mammary cell lines. The T-47D, MCF-7, SK-Br-3, AlAb 496, BT-20, and BT-474 tumor cell lines and a cell line (HBL-100) derived from milk exhibited EGF binding; both high (Ka 1010 M-1)- and low (Ka 109 M-1)-affinity sites were detected. The total number of EGF receptors per cell of different cell lines varied from 1.6 x 103 sites/cell (for AlAb 496) to 1.5 x 106 sites/cell (for BT-20). The two floating cell lines, DU4475 and Lev III, had no detectable EGF binding. Effect of EGF on growth was studied by monitoring cell number and the incorporation of [3H]thymidine into DNA of cells maintained in Dulbecco's modified Eagle's medium supplemented with 0.1% fetal bovine serum. Using these procedures, only T-47D cells were stimulated by EGF at low concentrations (0.1 to 1 ng/ml). At concentrations higher than 10 ng/ml, EGF was inhibitory to varying degrees in most cell lines that contained EGF receptors. The growth of the two floating cell lines that had no detectable EGF binding was unaffected by EGF. Our results show that EGF receptors are not present in all human breast cancer cell lines. There is no apparent correlation between EGF binding and its mitogenic activity in cell lines with EGF receptors. EGF may have biological roles in human breast cancer other than growth regulation.

1 Supported by the Medical Research Council of Canada and the National Cancer Institute of Canada. Portions of this work were reported at the Twenty-First Annual Meeting of the American Society for Cell Biology held in Anaheim, Calif., November 9 to 13, 1981 (14).

2 To whom requests for reprints should be addressed.

Received 2/ 4/82. Accepted 7/26/82.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Li and P. E. Shaw
Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines
J. Biol. Chem., May 10, 2002; 277(20): 17397 - 17405.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Leong, G. L. Firestone, and L. F. Bjeldanes
Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-{alpha} expression
Carcinogenesis, November 1, 2001; 22(11): 1809 - 1817.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Xie, R. Duan, I. Chen, I. Samudio, and S. Safe
Transcriptional Activation of Thymidylate Synthase by 17{beta}-Estradiol in MCF-7 Human Breast Cancer Cells
Endocrinology, July 1, 2000; 141(7): 2439 - 2449.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
E. K. Lobenhofer, G. Huper, J. D. Iglehart, and J. R. Marks
Inhibition of Mitogen-activated Protein Kinase and Phosphatidylinositol 3-Kinase Activity in MCF-7 Cells Prevents Estrogen-induced Mitogenesis
Cell Growth Differ., February 1, 2000; 11(2): 99 - 110.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. L. Arteaga, T. T. Ramsey, L. K. Shawver, and C. A. Guyer
Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site
J. Biol. Chem., September 12, 1997; 272(37): 23247 - 23254.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y.-s. Piao, H. Peltoketo, A. Jouppila, and R. Vihko
Retinoic Acids Increase 17{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in JEG-3 and T47D Cells, but the Stimulation Is Potentiated by Epidermal Growth Factor, 12-O-Tetradecanoylphorbol-13-Acetate, and Cyclic Adenosine 3',5'-Monophosphate Only in JEG-3 Cells
Endocrinology, March 1, 1997; 138(3): 898 - 904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.